GHRP-2: qué es y de dónde viene

Referencias científicas

Estudios publicados sobre este compuesto (fichas bibliográficas verificadas en Crossref). Son trabajos de laboratorio o en modelos animales: no demuestran eficacia ni seguridad en personas y no constituyen una recomendación de uso.

1. Vasylieva V, West A, Karpman E. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review (2026) Sexual Medicine Reviews. DOI: 10.1093/sxmrev/qeag078. PMID: 42862021.
2. Okada N, Nakagawa T, Murahashi N, Kurosu T, Kusuda S, Kaneko C. Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests (2026) Endocrine Journal. DOI: 10.1507/endocrj.ej26-0192. PMID: 42732957.
3. Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration (2026) Frontiers in Endocrinology. DOI: 10.3389/fendo.2026.1822475. PMID: 42395176.
4. Li Y, Yao L, Zhang C, Li T, Wang D, Li J. Growth Hormone–Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon‐Bone Healing Properties in a Rat Rotator Cuff Tear Model (2024) Arthroscopy. DOI: 10.1016/j.arthro.2024.11.094. PMID: 39672241.